abstract |
The present invention relates to compounds of formula (I) n n n n n n n n n n wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , m, and n are defined in the specification are TRPV1 antagonists. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. |